Status:

COMPLETED

PrEP Demonstration Study in Swaziland

Lead Sponsor:

Clinton Health Access Initiative Inc.

Collaborating Sponsors:

Ministry of Health, Swaziland

Heidelberg University

Conditions:

HIV Negative People Identified at Substantial Risk for HIV Infection

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

This stepped-wedge cluster-randomized trial is embedded in an 18-month observational cohort study that has the aim to assess the operationalization of oral Pre-Exposure Prophylaxis (PrEP) in Swaziland...

Detailed Description

The study will assess who will be reached with an introduction to and an offer of PrEP - and who will take up PrEP - when PrEP becomes available through different delivery points in the public-sector ...

Eligibility Criteria

Inclusion

  • Confirmed HIV negative by rapid antibody test following the National HIV testing services (HTS) algorithm on the day of PrEP initiation
  • \> 16 years of age
  • Willing and able to provide written informed consent
  • Identified at substantial risk of acquiring HIV infection
  • No current or recent illness (within past month) consistent with acute HIV infection in combination with a preceding high risk exposure for HIV
  • No contraindications to the use of Tenofovir(TDF)/Lamivudine (3TC)
  • Ready to adhere to PrEP and willing to attend the follow up evaluations including repeat HIV testing and monitoring for side-effects

Exclusion

  • Younger than 16 years of age
  • Currently having symptoms of acute HIV infection
  • Suspicion of window period following a potential exposure to HIV
  • Body weight \< 40 kg
  • Creatinine clearance \<60 ml/min
  • Using other nephrotoxic drugs (e.g. aminoglycosides)
  • Not willing to come for follow up visits every 3 months which will include HIV testing and counselling and monitoring for side-effects.

Key Trial Info

Start Date :

August 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 2 2019

Estimated Enrollment :

517 Patients enrolled

Trial Details

Trial ID

NCT03254550

Start Date

August 1 2017

End Date

March 2 2019

Last Update

July 11 2019

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Hhukwini Clinic

Hhukwini, Hhohho Region, Eswatini

2

Horo Clini

Horo, Hhohho Region, Eswatini

3

Ndvwabangeni Nazarene Clinic

Ndvwabangeni, Hhohho Region, Eswatini

4

Ndzingeni Nazarene Clinic

Ndzingeni, Hhohho Region, Eswatini